Survey Reveals Gaps in Understanding of Weight Loss Drugs in India

A recent survey conducted by the Physicians Committee for Responsible Medicine (PCRM) has highlighted significant gaps in understanding the function of injectable weight loss drugs among urban Indians. The survey, which involved 1,087 respondents from Chennai, Bangalore, Delhi, and Mumbai, revealed that while many individuals are aware of these medications, their knowledge of how they work is limited.

The study focused on GLP-1 receptor drugs, which have gained popularity as a quick solution for weight loss. Despite their rising profile, only 18% of participants correctly identified that these drugs primarily reduce appetite. In contrast, 26% mistakenly believed they burn fat directly, and 20% thought they increase metabolism. Additionally, 18% of respondents claimed they had never heard of these drugs, while another 18% admitted they did not know how they function.

Zeeshan Ali, a research program specialist at PCRM, emphasized the lack of access to weight loss resources in urban areas. The survey indicated that only 43% of respondents in Chennai felt they had effective options available to them. Despite the challenges, 93% of participants reported attempting to lose weight at least once in their lives, but only 19% successfully maintained that weight loss over the long term, underscoring the need for sustainable solutions.

The survey also addressed concerns regarding the side effects of injectable weight loss drugs. Approximately 30% of respondents acknowledged being aware of specific negative side effects, while 45% had heard general negative information without specific details. A significant majority, 81%, felt that media discussions surrounding weight loss medications tend to exaggerate their effectiveness.

Ali noted a growing interest in plant-based diets as an alternative to weight loss medications. In Chennai, 87% of participants expressed a preference for trying a plant-based diet over injectable drugs, despite a majority identifying as meat-eaters. If research demonstrated substantial weight loss results from a plant-based approach, 83% indicated they would seriously consider it.

Cost and sustainability issues are also critical factors influencing individuals’ decisions. At a price point of ₹15,000 per month, these medications are financially prohibitive for many. Research indicates that weight loss effects tend to plateau around 60 weeks, and individuals often regain weight after discontinuing the drugs.

Ali further explained the reasons respondents might consider switching to a plant-based diet, highlighting factors such as the absence of side effects, scientific evidence supporting effectiveness, and long-term sustainability. Despite only 1% of Indians currently adhering to a plant-based lifestyle, there is a pressing need to raise awareness about its potential benefits for weight management and overall health.